A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies
NCT00109707 · COMPLETED · phase1, phase2
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
ClinicalTrials.gov recordChronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
NCT00123474 · COMPLETED · phase3
Myeloid Leukemia, Chronic, Chronic-Phase
ClinicalTrials.gov recordAdvanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
NCT00123487 · COMPLETED · phase3
Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
ClinicalTrials.gov recordStudy Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
NCT00261846 · COMPLETED · phase2
Chronic Myeloid Leukemia
ClinicalTrials.gov recordA Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
NCT00471497 · COMPLETED · phase3
Myelogenous Leukemia, Chronic
ClinicalTrials.gov recordA Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
NCT00481247 · COMPLETED · phase3
Myeloid Leukemia, Chronic
ClinicalTrials.gov recordPonatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)
NCT01207440 · COMPLETED · phase2
Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia
ClinicalTrials.gov recordTreatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
NCT01698905 · COMPLETED · phase2
Chronic Myeloid Leukemia
ClinicalTrials.gov recordNilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
NCT01784068 · COMPLETED · phase2
Chronic Myelogenous Leukemia
ClinicalTrials.gov recordA Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL
NCT02081378 · COMPLETED · phase1
Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
ClinicalTrials.gov recordA Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT02130557 · COMPLETED · phase3
Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
ClinicalTrials.gov recordPonatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses
NCT02467270 · COMPLETED · phase2
Myeloid Leukemia, Chronic, Chronic Phase
ClinicalTrials.gov recordStudy of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
NCT03106779 · COMPLETED · phase3
Chronic Myelogenous Leukemia
ClinicalTrials.gov recordA Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226 · ACTIVE NOT RECRUITING · phase3
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
ClinicalTrials.gov recordTherapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
NCT00038675 · COMPLETED · na
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera, Hypereosinophilic Syndrome, Mastocytosis
ClinicalTrials.gov record3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
NCT00381550 · COMPLETED · phase2
Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Chronic Eosinophilic Leukemia,...
ClinicalTrials.gov recordFludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
NCT00397813 · COMPLETED · phase2
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Essential Thrombocythemia, Myeloproliferative Neoplasm,...
ClinicalTrials.gov recordAflibercept in Treating Patients With Myelodysplastic Syndromes
NCT00509249 · TERMINATED · phase2
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm,...
ClinicalTrials.gov recordReduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
NCT00579111 · TERMINATED · phase1, phase2
Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Plasma Cell...
ClinicalTrials.gov recordClofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
NCT00626626 · TERMINATED · phase1, phase2
Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma
ClinicalTrials.gov recordPilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
NCT01338987 · COMPLETED · phase2
Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia
ClinicalTrials.gov recordBone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps
NCT01350258 · TERMINATED · phase1, phase2
Hematologic Malignancies, Acute Leukemia, Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myeloma, Chronic...
ClinicalTrials.gov recordReduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
NCT02145039 · TERMINATED · na
Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia
ClinicalTrials.gov recordSafety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
NCT02639559 · COMPLETED · phase2
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Non-Hodgkin's Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Disease, Hodgkins Disease,...
ClinicalTrials.gov recordReduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT02988466 · COMPLETED · phase2
Hematologic Malignancies
ClinicalTrials.gov recordCalcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
NCT03018223 · COMPLETED · phase1
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia, Primary Myelofibrosis, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Hodgkin...
ClinicalTrials.gov record